These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 19500289)

  • 41. Enteral formula feeds interfere with phenytoin absorption.
    O'Hagan M; Wallace SJ
    Brain Dev; 1994; 16(2):165-7. PubMed ID: 8048710
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phenytoin: an old friend that still confuses us.
    Bamberg K
    JAAPA; 2012 Feb; 25(2):17. PubMed ID: 22416548
    [No Abstract]   [Full Text] [Related]  

  • 43. Fosphenytoin and status epilepticus.
    Brown J
    Hosp Med; 1999 Jan; 60(1):70-1. PubMed ID: 10197108
    [No Abstract]   [Full Text] [Related]  

  • 44. Sodium valproate vs phenytoin in status epilepticus: a pilot study.
    Rossetti AO
    Neurology; 2007 Feb; 68(9):709; author reply 709. PubMed ID: 17325288
    [No Abstract]   [Full Text] [Related]  

  • 45. Is the phenytoin-enteral feeding formula interaction a myth?
    Bertino JS
    Nutr Clin Pract; 1996 Aug; 11(4):175-6. PubMed ID: 9070019
    [No Abstract]   [Full Text] [Related]  

  • 46. Interaction between levofloxacin and phenytoin: report of two cases.
    Catalá Ripoll JV; Domingo Chiva E; Marco Del Río J
    Med Clin (Barc); 2017 Sep; 149(6):278-279. PubMed ID: 28571955
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of 'Mentat' on the pharmacokinetics of single and multiple doses o phenytoin in rabbits.
    Garg SK; Islam AS; Kumar N; Sehgal M; Bhargava VK
    Neurol India; 1999 Jun; 47(2):104-7. PubMed ID: 10402333
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Precision, bias, and clinical utility of the Sheiner-Tozer equation to guide phenytoin dosing in critically ill adults.
    Bolt J; Gorman SK
    J Clin Pharmacol; 2013 Apr; 53(4):451-5. PubMed ID: 23436385
    [No Abstract]   [Full Text] [Related]  

  • 49. Life-threatening cardiotoxicity due to chronic oral phenytoin overdose.
    Su CM; Kung CT; Wang YC; Lu CH
    Neurol India; 2009; 57(2):200-2. PubMed ID: 19439856
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factors affecting antiepileptic drug pharmacokinetics in community-dwelling elderly.
    Cloyd JC; Marino S; Birnbaum AK
    Int Rev Neurobiol; 2007; 81():201-10. PubMed ID: 17433925
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The use of free phenytoin levels in averting phenytoin toxicity.
    Gordon MF; Gerstenblitt D
    N Y State J Med; 1990 Sep; 90(9):469-70. PubMed ID: 2293123
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of dexamethasone on the decrease of serum phenytoin concentrations.
    Recuenco I; Espinosa E; García B; Carcas A
    Ann Pharmacother; 1995 Sep; 29(9):935. PubMed ID: 8547745
    [No Abstract]   [Full Text] [Related]  

  • 53. [Results of statistical analysis with a computer of the median effective dose and plasma levels of drugs in the treatment of epilepsy].
    Oller L; Lagunas Hernandez MA; Russi Tintore A; Sabater Tobella J; Oller Daurella L
    Arch Neurobiol (Madr); 1977; 40(1):37-46. PubMed ID: 856097
    [No Abstract]   [Full Text] [Related]  

  • 54. Timely antemortem and postmortem concentrations in a fatal carbamazepine overdose.
    Spiller HA; Carlisle RD
    J Forensic Sci; 2001 Nov; 46(6):1510-2. PubMed ID: 11714170
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phenytoin induced status epilepticus.
    Al-Khulaif AH; Shujaa AS
    Neurosciences (Riyadh); 2010 Apr; 15(2):131-2. PubMed ID: 20672505
    [No Abstract]   [Full Text] [Related]  

  • 56. Phenytoin induced status epilepticus.
    Al-Mendalawi MD
    Neurosciences (Riyadh); 2010 Oct; 15(4):295. PubMed ID: 20956935
    [No Abstract]   [Full Text] [Related]  

  • 57. Benefits of a clinical pharmacokinetic service in optimising phenytoin use in the western Cape.
    Valodia P; Seymour MA; Kies BM; Folb PI
    S Afr Med J; 1998 Jul; 88(7):873-5. PubMed ID: 9698715
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug interaction assessment following concomitant administration of posaconazole and phenytoin in healthy men.
    Krishna G; Sansone-Parsons A; Kantesaria B
    Curr Med Res Opin; 2007 Jun; 23(6):1415-22. PubMed ID: 17559737
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Purple glove syndrome occurring after oral administration of phenytoin in therapeutic doses: mechanism still a dilemma.
    Jain RS; Nagpal K; Kumar S; Prakash S; Handa R
    Am J Emerg Med; 2015 Jan; 33(1):123.e5-6. PubMed ID: 25064142
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fosphenytoin facts.
    Chioffi SM; Lassiter TF; Scates AC; McLendon BM
    Am J Nurs; 1999 Aug; 99(8):14. PubMed ID: 10456012
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.